Full article: Novel multi-target ligands of dopamine and serotonin
Por um escritor misterioso
Descrição
Ligand with Two Modes of Interaction with the Dopamine D2 Receptor–An Induced-Fit Mechanism of Insurmountable Antagonism
IJMS, Free Full-Text
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease - ScienceDirect
Biomedicines, Free Full-Text
Frontiers Prolonged Amphetamine Exposures Increase the Endogenous Human Dopamine Receptors 2 at the Cellular Membrane in Cells Lacking the Dopamine Transporter
Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives - ScienceDirect
a-j Chemical structures of endogenous ligands used: a serotonin, b
Pharmaceuticals, Free Full-Text
Update on GPCR-based targets for the development of novel antidepressants
The Efficiency of Multi-target Drugs: A Network Approach
Fluorescent ligands for dopamine D2/D3 receptors
Pathways of dopamine (A) and serotonin (B) metabolism. *, target analytes.
Full article: Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation
Biomolecules, Free Full-Text
PDF) Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases
de
por adulto (o preço varia de acordo com o tamanho do grupo)
